Pankovcin Corinne 4
4 · Aditx Therapeutics, Inc. · Filed Jun 8, 2021
Insider Transaction Report
Form 4
Pankovcin Corinne
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2021-06-04+55,000→ 169,220 total
Footnotes (1)
- [F1]The restricted common stock vests in three (3) successive equal annual installments, which began on March 31, 2021.